Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$1.0 - $1.53 $54,597 - $83,533
-54,597 Reduced 16.2%
282,467 $432,000
Q3 2023

Nov 13, 2023

BUY
$1.06 - $2.33 $2,981 - $6,554
2,813 Added 0.84%
337,064 $367,000
Q2 2023

Aug 10, 2023

BUY
$2.15 - $3.49 $270,723 - $439,453
125,918 Added 60.44%
334,251 $765,000
Q1 2023

May 09, 2023

BUY
$1.99 - $2.68 $146,814 - $197,719
73,776 Added 54.83%
208,333 $506,000
Q4 2022

Feb 10, 2023

BUY
$1.8 - $2.56 $242,202 - $344,465
134,557 New
134,557 $257,000
Q1 2021

May 13, 2021

SELL
$3.45 - $9.09 $166,459 - $438,583
-48,249 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.05 - $3.67 $65,114 - $227,591
-62,014 Reduced 56.24%
48,249 $165,000
Q3 2020

Nov 12, 2020

BUY
$1.44 - $2.1 $56,666 - $82,639
39,352 Added 55.49%
110,263 $159,000
Q2 2020

Aug 13, 2020

BUY
$1.75 - $2.3 $47,619 - $62,585
27,211 Added 62.27%
70,911 $141,000
Q1 2020

May 13, 2020

BUY
$1.8 - $4.28 $78,660 - $187,036
43,700 New
43,700 $85,000
Q1 2018

May 14, 2018

SELL
$7.86 - $11.39 $318,919 - $462,149
-40,575 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$8.77 - $12.28 $245,560 - $343,840
28,000 Added 222.66%
40,575 $401,000
Q3 2017

Nov 14, 2017

BUY
$12.17 - $16.3 $153,037 - $204,972
12,575
12,575 $155,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.